The current invention relates to a medical device to be positioned within the main pulmonary artery and/or the pulmonary artery branches, and to methods of use thereof for treating, reducing the severity of, or reducing symptoms associated with, or any combination thereof, congestive heart failure, including left ventricular failure, wherein use may in certain embodiments, affect the position and function of the interventricular septum during systole.
Congestive heart failure (CHF) means the heart does not pump out sufficient blood to meet the body's demands. CHF can result from either a reduced ability of the heart muscle to contract (systolic failure) or from a mechanical problem that limits the ability of the heart's chambers to fill with blood (diastolic failure). When weakened, the heart is unable to keep up with the demands placed upon it and the left ventricle (LV) gets backed up or congested. CHF is a progressive disease. Failure of the left side of the heart (left-heart failure/left-sided failure/left-ventricle failure) is the most common form of the disease.
CHF affects people of all ages including children, but it occurs most frequently in those over age 60, and is the leading cause of hospitalization and death in that age group. Current treatments of CHF include lifestyle changes, medications, and surgery to bypass blocked blood vessels, replace regurgitant or stenotic valves, install stents to open narrowed coronary vessels, install pump assist devices or transplantation of the heart.
Normal cardiac contraction is a finely tuned orchestrated activity dependent on muscle function, ventricular geometry and loading conditions termed preload and afterload. When CHF due to LV systolic failure occurs, it is typically associated with changes in the geometry of the ventricles, often called remodeling. The LV becomes dilated and the interventricular septum is deflected into the right ventricle (RV), resulting in decreased LV output/pumping efficiency. The efficient systolic function of the LV is dependent not only on the strength of the myocardium but also on the LV geometry, the position and shape of the interventricular septum and the geometry and function of the RV. Interventricular dependence has been documented in experimental studies which have evaluated both normal and pathological preparations in animals. LV systolic function can be directly influenced by interventions affecting the RV and the position of the interventricular septum.
Surgical pulmonary artery banding (PAB) is a technique that was described more than 60 years ago and is still in use today for children and infants with congenital heart defects, such as overflow of blood to the lungs and volume overload of the RV. PAB is typically performed through a thoracotomy and involves wrapping a band around the exterior of the main pulmonary artery (MPA) and fixing the band in place, often with the use of sutures. Once applied, the band is tightened, narrowing the diameter of the MPA, increasing resistance to flow, reducing blood flow to the lungs, and reducing downstream pulmonary artery (PA) pressure.
Surgical PAB procedures involve the risks present with all surgical procedures. In addition, use of PAB has a number of particular disadvantages and drawbacks. Primary among these drawbacks is the inability of the surgeon performing the procedure to accurately assess, from the hemodynamic standpoint, the optimal final diameter to which the PA should be adjusted. Often, the surgeon must rely upon his or her experience in adjusting the band to achieve acceptable forward flow while decreasing the blood flow sufficiently to protect the pulmonary vasculature.
It is also not uncommon for the band to migrate towards one of the main pulmonary branches (usually the left), resulting in stenosis of the other main pulmonary branch (usually the right). There have also been reports of hardening of the vessels around the band due to buildup of calcium deposits and scarring of the PA wall beneath the band, which can also inhibit blood flow. Flow resistance due to PAB may change over time, and additional surgeries to adjust band tightness occur in up to one third of patients. The band is typically removed in a subsequent operation, for example, when a congenital malformation is corrected in the child or infant.
In addition to the classical use of PAB for treatment of congenital defects in infants and children, there has been a recent report of use of surgical PAB for left ventricle dilated cardiomyopathy (LVDCM) in infants and young children. This method includes increasing the pressure load on the right ventricle by placing a band around the pulmonary artery. The increased pressure in the right ventricle caused a leftward shift of the interventricular septum and improvement of left ventricle function. It was found that the optimal degree of constriction was achieved when the RV pressure was approximately 60% to 70% of the systemic level and so that the interventricular septum slightly moved to a midline position. The success of these procedures in infants and children has been reported to be possibly due to the potential for myocyte recovery and repopulation being significantly greater for infants and young children than for adults. However, it is the position of the inventors that the geometric improvements to the failing heart due to PAB may be responsible, at least partially, for the observed improvements in LV function, and therefore PAB for adult left ventricle heart failure may demonstrate similar improvement in LV function.
The MPA is not a favorable location for positioning an implant due to its relatively large diameter (˜30 mm) and short length (˜50 mm). The full length of the MPA is not usable for an implant due to the proximity to the pulmonary valve on one end, and the bifurcation to the pulmonary branches on the other. It is estimated that the usable length of the MPA for the implant is approximately 30 mm. Implantation of a short, wide device into the MPA is very difficult, and there is significant danger that the device will rotate or otherwise not be placed concentric with the MPA, in which case near complete blockage of the MPA could occur. In addition, the device may erroneously be placed either too close to the pulmonary valve or to the bifurcation.
It would be desirable to provide a relatively simple medical apparatus which could be implanted in a minimally-invasive fashion, and which would allow an adjustment of blood flow through a vessel. Gradual reduction in the diameter of the MPA may be desirable, but is not currently feasible with the surgical PAB approaches described above. In addition, it would be desirable to use the medical apparatus for treatment of the mature adult population suffering from left ventricle (LV) failure.
The methods and apparatuses of this invention describe a medical apparatus configured to reduce a diameter of a blood vessel for treating or at least reducing the severity of a congestive failure of the heart, such as but not limited to: systolic heart failure, diastolic heart failure, left ventricle (LV) heart failure, right ventricle (RV) heart failure, congenital defects of the heart for which surgical pulmonary artery banding (PAB) is used, and any other condition which requires pulmonary artery banding (PAB).
Some embodiments of the present invention provide a medical apparatus for deployment within an anatomical blood vessel comprising:
In some embodiments, the first tubular wall is connected at least at one end to the second tubular wall.
In some embodiments, at least a portion of the second tubular wall is coated with a coating material.
In some embodiments, the first and second tubular walls are concentric.
In some embodiments, material of the first and second tubular walls comprises at least one of the group consisting of: Nitinol, stainless steel, Titanium, Cobalt-Chromium alloy, Tantalum alloy, polymer, Platinum alloy and any combination thereof.
In some embodiments, the first tubular wall is made of a first material and the second tubular wall is made of a second material.
In some embodiments, the first and second tubular walls are manufactured by a process selected from: laser cutting, braiding, any combination thereof.
In some embodiments, the ratio between the medical apparatus's longitudinal length (L) and diameter of the first tubular wall (Dout) is smaller than 2.
In some embodiments, the constricting element comprises a loop section.
In some embodiments, the second tubular wall comprises at least one fixation element, configured to anchor the loop section and prevent it from longitudinal movement.
In some embodiments, the constriction element further comprises a tail section configured to be pulled and/or pushed to adjust the circumference of the loop section.
In some embodiments, the circumference of the loop section is locked at the adjusted circumference
In some embodiments, the tail is configured to be detached after adjustment of the loop section circumference.
In some embodiments, the tail section is configured to extend out of the blood vessel and into a subcutaneous space.
In some embodiments, the constricting element is configured for circumference adjustment of the second tubular wall, while the medical apparatus is within the anatomic vessel.
In some embodiments, the constriction provides the second tubular wall with a radial neck section, configured for reduction of the effective diameter of the anatomical blood vessel.
In some embodiments, the medical apparatus is collapsible and configured to be delivered into the anatomic vessel via a catheter.
Some embodiments of the present invention provide a method for reduction of effective diameter of an anatomic vessel comprising:
In some embodiments, the step of constricting is configured for forming a diametrical reducer for the anatomical blood vessel.
In some embodiments, the step of providing further comprises providing the medical apparatus with a constricting element configured for the constricting of the portion of the second tubular wall.
In some embodiments, the constricting element comprises a loop section and a tail section.
In some embodiments, the step of constricting further comprises adjusting the constriction, before, during, and/or after the step of the deploying.
In some embodiments, the step of the deploying comprises delivering the medical apparatus into the anatomical blood vessel via a catheter.
In some embodiments, the method further comprises a step of expanding the constricted portion of the second tubular wall, while within the anatomical blood vessel.
In some embodiments, the method further comprises a step of temporarily or permanently locking the constricted section of the second tabular wall to a specific circumference.
In some embodiments, the method further comprises a step of detaching the tail section from the constricting element.
In some embodiments, the method further comprises monitoring at least one physiological parameter.
The subject matter regarded as the invention is particularly pointed out and distinctly claimed in the concluding portion of the specification. The invention, however, both as to organization and method of operation, together with objects, features, and advantages thereof, may be understood by reference to the following detailed description when read with the accompanying drawings in which:
It will be appreciated that for simplicity and clarity of illustration, elements shown in the figures have not necessarily been drawn to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.
The following description is provided, alongside all chapters of the present invention, so that to enable any person skilled in the art to make use of the invention and sets forth the best modes contemplated by the inventor of carrying out this invention. Various modifications, however, will remain apparent to those skilled in the art, since the generic principles of the present invention have been defined specifically to provide a medical apparatus configured to reduce a diameter of a blood vessel for treating or at least reducing the severity of a congestive failure of the heart, such as but not limited to: systolic heart failure, diastolic heart failure, left ventricle (LV) heart failure, right ventricle (RV) heart failure, congenital defects of the heart for which surgical pulmonary artery banding (PAB) is used, and any other condition which requires pulmonary artery banding (PAB).
As used herein, in one embodiment, the term “about”, refers to a deviance of between 0.0001-5% from the indicated number or range of numbers. In one embodiment, the term “about”, refers to a deviance of between 1-10% from the indicated number or range of numbers. In one embodiment, the term “about”, refers to a deviance of up to 25% from the indicated number or range of numbers.
According to some embodiments, the term “a” or “one” or “an” refers to at least one.
According to some embodiments the present invention provides a stent-like medical apparatus, as demonstrated at least in
According to some embodiments, the medical apparatus (100) comprising:
According to some embodiments, the combination of the outer tubular wall (110), the inner tubular wall (120) and the constricting element (130) forms a diametrical reducer, which is suitable to be implanted within an anatomical blood vessel (150).
According to some embodiments, the constriction (121) provides the inner tubular wall (120) with a radial neck section (125). According to some embodiments, the neck section (125) is configured for reduction of the effective diameter of an anatomical blood vessel (150). According to some embodiments a gradual adjustment of the constricting element (130) can cause a gradual reduction of the effective diameter of the anatomical blood vessel.
According to some embodiments, the inner and outer tubular walls (110,120) are connected at their proximal ends (as demonstrated at least in
According to some embodiments, in the case where the inner and outer tubular walls are connect at only one end (distal or proximal), the constriction or an adjustment of the constriction can cause a change in the overall longitudinal length (Lin) of the inner tubular wall (120).
According to some embodiments, the medical apparatus further comprises an arched section (140), for a non-limiting example a torus-like portion (as demonstrated at least in
According to some embodiments, the outer and inner tubular walls (110,120) are concentric. According to some embodiments, the medical apparatus is axisymmetric.
According to some embodiments, the material of the outer and inner tubular walls comprises at least one from the group consisting of: Nitinol, stainless steel, Titanium, Cobalt-Chromium alloy, Tantalum alloy, polymer, Platinum alloy and any combination thereof.
According to some embodiments, the outer tubular wall is made of a first material and the inner tubular wall is made of a second material. According to some embodiments, the outer and inner tubular walls are made of the same material.
According to some embodiments, at least a part of the inner tubular wall is coated (128), as demonstrated in
According to some embodiments, at least one of the outer and inner tubular walls (110,120) is made of a collapsible memory shape material, therefore self-expanding material. According to some embodiments, at least one of the outer and inner tubular walls (110,120) is manufactured by laser cut process. According to some embodiments, at least one of the outer and inner tubular walls (110,120) is manufactured by braiding. According to a preferred embodiment the outer tubular wall (110) is manufactured by a laser cut process and the inner tubular wall (120) is manufactured by braiding (as shown in
According to some embodiments, the ratio between the medical apparatus's (100) longitudinal length (L) and the diameter of the outer tubular wall (Dout) is smaller than a predetermined numeral (N=L/Dout) selected from the group consisting of: 3, 2.5, 2, 1.5, 1, 0.5, 0.3 and any ratio within this range. According to a preferred embodiment, N is smaller than 1.5. The dimension annotations for the medical apparatus can be found in
According to some embodiments, the constricting element (130) comprises a loop section (131), which can comprise one of: a ring, a band, a hoop, a noose, a hitch and any combination thereof.
According to some embodiments, the circumference of the loop section (131) is predetermined and fixed before delivery into the anatomical blood vessel. According to some embodiments, the circumference of the loop section (131) can be adjusted. The circumference adjustment can be conducted prior to the insertion of the medical apparatus (100) into the anatomical blood vessel (150). For a non-limiting example, a physician's (or a care giver) prior to insertion adjustment is according to the patient's clinical condition. Alternatively, the circumference adjustment can be conducted while the medical apparatus is within the blood vessel (150), e.g. during the implantation procedure and/or any time after implantation. According to some embodiments the adjustment can be gradual, i.e., over hours, days or weeks after implantation. According to some embodiments, the adjustable loop section (131) can be only tightened, and according to some embodiments it can be expandable as well, for a non-limiting example the adjustable loop section (131) can be expanded by an inflatable balloon (330), as demonstrated in
According to some embodiments, the loop section (131) can be positioned at any location along the longitudinal axis X of the inner tubular wall (120). According to some embodiments, the loop section (131) is deployed at a predetermined location, prior to insertion of the medical apparatus to the blood vessel (150), as demonstrated in
According to some embodiments, the loop section (131) is fixated at a particular location along the longitudinal axis X by at least partially weaving the loop section (131) through the struts of the outer tubular wall (110), as demonstrated in
According to some embodiments, the medical apparatus (100) is collapsible and self-expanding and is configured to be delivered into an anatomical blood vessel (150) via a delivering system, e.g. a catheter (310), as demonstrated in
According to some embodiments, the constricting element (130) further comprises a tail section (132) configured to be pulled (or pushed, if the tail section is non-flexible), in some embodiments, by a mechanism in the handle of the delivery system and thereby adjust the circumference of the loop section (131) and accordingly the neck section (125) of the inner tubular wall.
According to some embodiments, the constricting element comprises an adjusting mechanism (320). In one embodiment, the adjusting mechanism (320) comprises a folded wire, where the folded section is passed through a tube element (321) and forms the loop section (136), which extends out the distal end of the tube element (321), and where two tail section/s (132) extend out of the proximal end of the tube element (321). In another embodiment the adjusting mechanism (320) comprises a looped wire with a sliding knot (hence the loop section), with the single wire passed through a tube element (321) and extending out of its distal end, and where the wire's single tail (hence tail section), extends out of the tube element's (321) proximal end. According to both adjusting mechanism (320) examples, by pulling the wire's tail section/s (132), while holding the tube element (321) stationary, the wire's loop section (136) is tightened and thereby its circumference is reduced.
According to some embodiment, the proximal end of the adjusting mechanism (320) can be extended out of the blood vessel and into a subcutaneous space, which can provide access for post procedure adjustment (e.g. post implantation adjustment). More specifically, the wire's tail section/s (132) together with the proximal end of the tube element (321) can be extended out of the blood vessel and into a subcutaneous space.
According to some embodiments, the tail section (132) extends out of the blood vessel, for a non-limiting example, through the right side of the heart and to a subcutaneous space. According to some embodiments, an actuator (350) can further pull and/or push the proximal end of the tail section (132) for adjustment of the circumference of the loop section (131) of the constricting element (130), as demonstrated in
According to some embodiments, the loop section (131), after its circumference adjustment, can be temporarily or permanently fixed or locked to the selected circumference, and according to some embodiments, the tail section (132) can be detached (133) from the loop section (131), for a non-limiting example, at a point near the medical apparatus, as demonstrated in
According to some embodiments, the medical apparatus (100) is delivered as a single tubular wall (115) where the inner tubular (120) wall is formed by radially folding at least one end (distal and/or proximal end) of the single tubular wall (115) there-into and into the loop section (130), and thereby to form the inner tubular wall (120) with a diameter Din<Dout. According to some embodiments, the folding and forming of the inner tubular wall (120) can be conducted at a prior stage, e.g. at the manufacturing stage, as demonstrated in
According to some embodiments the present invention provides a method (200) for reducing the effective diameter of an anatomic vessel (150). The method (200) comprising steps of:
According to some embodiments, the step of constricting (230) is configured for forming a diametrical reducer for the anatomical blood vessel (150). According to some embodiments, the constricting is gradual, by means of step wise constriction over a predetermined period of time, for a non-limiting example, every couple of days or weeks; which can lead to a gradual and controlled reduction of the effective diameter of the anatomical blood vessel.
According to some embodiments, the step of providing (210) further comprises providing (211) the medical apparatus with a constricting element (130) configured for the constricting of the portion (121) of the inner tubular wall (120). According to some embodiments, the constricting element (130) comprises a loop section (131) and can further comprise a tail section (132), as detailed above.
According to some embodiments, the step of constricting (230) further comprises adjusting (231) the constriction. Adjusting the constriction can be at any time of the treatment procedure, i.e. before deployment of the medical apparatus (as in
According to some embodiments, the adjusting can be gradual, for gradual and controlled adjustment of the effective diameter of the anatomical blood vessel.
According to some embodiments, the step of deploying (220) comprises delivering (221) the medical apparatus by a trans-catheter procedure into the anatomical blood vessel (150) via a catheter (310), as demonstrated in
According to some embodiments, the method (200) further comprises a step of expanding (240) the constricted portion of the inner tubular wall, while within the anatomical blood vessel (150), for a non-limiting example: by an inflatable balloon (330), delivered and controlled by a catheter (331), as demonstrated in
According to some embodiments, the method (200) further comprises a step of temporarily or permanently locking (250) the constricted section of the inner tabular wall (120) to a specific circumference. According to some embodiments, the locking can be performed by using a locking mechanism (372) for the constricted area of the inner tubular wall (120), for a non-limiting example as demonstrated in
According to some embodiments, the method (200) further comprises a step of detaching (260) the tail section (132) of the constricting element (130), according to some embodiments after the step of locking (250), as demonstrated in
According to some embodiments, in the case where the medical apparatus (100) is delivered as a single tubular wall (115), the providing (210) comprises forming (212) the inner tubular wall (120) by pushing in at least one end-portion (111) of the single tubular wall (115) and radially folding thereof into. According to some embodiments, the step of forming (212) can be performed before the step of deploying (220) the medical apparatus; according to other embodiments the step of forming (212) can be performed after the step of deploying (220), while the medical apparatus (100) is within the anatomical blood vessel (150), by using a catheter (360). According to a preferred embodiment, the forming (212), before or while the medical apparatus is within the blood vessel, can be achieved when at least part of the single tubular wall (115) is manufactured by a braiding process.
According to some embodiments, the method (200) further comprises monitoring (270) at least one physiological parameter, in order examine the effects of treatment by use of the medical apparatus. According to some embodiments, the monitoring (270) is performed during at least one of the steps of: deploying (220), delivering (221), forming (212), constricting (230), adjusting (231), expanding (240), locking (250) and detaching (260). According to a preferred embodiment, the monitoring (270) is configured for the adjusting (231) of the constriction of the inner tubular wall (120). According to some embodiments, the at least one monitored physiological parameter can be compared to a baseline reading of the same (e.g. prior to treatment), in order examine the effects of treatment.
According to some embodiments, monitoring (270), comprises at least one of:
According to some embodiments, a therapeutic result for the use of the medical apparatus (100) can be at least one of the group consisting of:
Reference is now made to
Reference is now made to
Reference is now made to
According to a preferred embodiment, the forming, before or while the medical apparatus is within the blood vessel, can be achieved when at least part of the single tubular wall (115) is manufactured by a braiding process.
Reference is now made to
Reference is now made to
A counter-force holding the tube element (321) stationary, while the wire tail/s (132) is/are pulled or pushed, can tighten or expand the circumference of the wire loop section (136), respectively.
According to some embodiments, the tube element and the wire tail section extend out of the blood vessels and to a subcutaneous space for access for later adjustment. According to other embodiments the tube and the wire tail are connected to, and operated by, the delivery system.
Reference is now made to
Reference is now made to
Reference is now made to
According to a non-limiting example of
The forming is conducted by the delivery system (310) having a tubular pushing tube (360).
Reference is now made to
Reference is now made to
Reference is now made to
Reference is now made to
Reference is now made to
Reference is now made to
Reference is now made to
While certain features of the invention have been illustrated and described herein, many modifications, substitutions, changes, and equivalents will now occur to those of ordinary skill in the art. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the invention.
All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting. In addition, any priority document(s) of this application is/are hereby incorporated herein by reference in its/their entirety.
This application is a continuation of U.S. patent application Ser. No. 15/716,667 filed on Sep. 27, 2017, which claims the benefit of U.S. Provisional Patent Application No. 62/400,695 filed on Sep. 28, 2016. The contents of the above applications are all incorporated by reference as if fully set forth herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3730186 | Edmunds, Jr. et al. | May 1973 | A |
4183102 | Guiset | Jan 1980 | A |
4425908 | Simon | Jan 1984 | A |
4601718 | Possis et al. | Jul 1986 | A |
4950276 | Vince | Aug 1990 | A |
5156620 | Pigott | Oct 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5330528 | Lazim | Jul 1994 | A |
5332403 | Kolff | Jul 1994 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5423851 | Samuels | Jun 1995 | A |
5554180 | Turk | Sep 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5618301 | Hauenstein et al. | Apr 1997 | A |
5662711 | Douglas | Sep 1997 | A |
5683411 | Kavteladze et al. | Nov 1997 | A |
5755779 | Horiguchi | May 1998 | A |
6120534 | Ruiz | Sep 2000 | A |
6312462 | McDermott et al. | Nov 2001 | B1 |
6471635 | Forsell | Oct 2002 | B1 |
6533800 | Barbut | Mar 2003 | B1 |
6562066 | Martin | May 2003 | B1 |
6595980 | Barbut | Jul 2003 | B1 |
6616624 | Kieval | Sep 2003 | B1 |
6638257 | Amplatz | Oct 2003 | B2 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6936057 | Nobles | Aug 2005 | B1 |
6953476 | Shalev | Oct 2005 | B1 |
7001409 | Amplatz | Feb 2006 | B2 |
7128750 | Stergiopulos | Oct 2006 | B1 |
7158832 | Kieval et al. | Jan 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7331993 | White | Feb 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7497873 | Bruckheimer | Mar 2009 | B1 |
7670367 | Chouinard et al. | Mar 2010 | B1 |
7862502 | Pool et al. | Jan 2011 | B2 |
7935144 | Robin et al. | May 2011 | B2 |
7983765 | Doan et al. | Jul 2011 | B1 |
7998220 | Murphy | Aug 2011 | B2 |
8070708 | Rottenberg et al. | Dec 2011 | B2 |
8091556 | Keren et al. | Jan 2012 | B2 |
8556954 | Ben MuVhar et al. | Oct 2013 | B2 |
8597349 | Alkhatib | Dec 2013 | B2 |
8663314 | Wood et al. | Mar 2014 | B2 |
8696611 | Nitzan et al. | Apr 2014 | B2 |
8764772 | Tckulve | Jul 2014 | B2 |
8808356 | Braido et al. | Aug 2014 | B2 |
8858612 | Ben-Muvhar et al. | Oct 2014 | B2 |
8911489 | Ben-Muvhar | Dec 2014 | B2 |
8940040 | Shahriari | Jan 2015 | B2 |
9034034 | Nitzan et al. | May 2015 | B2 |
9125567 | Gross et al. | Sep 2015 | B2 |
9393384 | Kapur et al. | Jul 2016 | B1 |
9474839 | Oran et al. | Oct 2016 | B2 |
9532868 | Braido | Jan 2017 | B2 |
9572661 | Robin et al. | Feb 2017 | B2 |
9603708 | Robin et al. | Mar 2017 | B2 |
9629715 | Nitzan et al. | Apr 2017 | B2 |
9649480 | Sugimoto et al. | May 2017 | B2 |
9668861 | McGuckin, Jr. | Jun 2017 | B2 |
9681948 | Levi et al. | Jun 2017 | B2 |
9681949 | Braido et al. | Jun 2017 | B2 |
9687242 | Hendriksen et al. | Jun 2017 | B2 |
9707382 | Nitzan et al. | Jul 2017 | B2 |
9713696 | Yacoby et al. | Jul 2017 | B2 |
9724499 | Rottenberg et al. | Aug 2017 | B2 |
9744059 | Ben-Muvhar | Aug 2017 | B2 |
9775636 | Fazio et al. | Oct 2017 | B2 |
9849006 | Kozyak et al. | Dec 2017 | B2 |
10010328 | Cragg | Jul 2018 | B2 |
10022128 | Bödewadt et al. | Jul 2018 | B2 |
10492933 | Jenni | Dec 2019 | B2 |
10568634 | Goldie et al. | Feb 2020 | B2 |
10667931 | Bruckheimer et al. | Jun 2020 | B2 |
10835394 | Nae et al. | Nov 2020 | B2 |
10912645 | Rottenberg et al. | Feb 2021 | B2 |
11135054 | Nitzan et al. | Oct 2021 | B2 |
11224503 | Karavany et al. | Jan 2022 | B2 |
11253685 | Fahey et al. | Feb 2022 | B2 |
11357610 | Karavany et al. | Jun 2022 | B2 |
11364132 | Bellomo et al. | Jun 2022 | B2 |
20010053330 | Ozaki | Dec 2001 | A1 |
20020107536 | Hussein | Aug 2002 | A1 |
20030032976 | Boucek | Feb 2003 | A1 |
20030097172 | Shalev et al. | May 2003 | A1 |
20030144575 | Forsell | Jul 2003 | A1 |
20030149473 | Chouinard et al. | Aug 2003 | A1 |
20030167068 | Amplatz | Sep 2003 | A1 |
20030236568 | Hojeibane et al. | Dec 2003 | A1 |
20040077988 | Tweden et al. | Apr 2004 | A1 |
20040111006 | Alferness et al. | Jun 2004 | A1 |
20040236412 | Brar et al. | Nov 2004 | A1 |
20050055082 | Ben Muvhar | Mar 2005 | A1 |
20050096734 | Majercak et al. | May 2005 | A1 |
20050148925 | Rottenberg et al. | Jul 2005 | A1 |
20050165344 | Dobak, III | Jul 2005 | A1 |
20050171556 | Murphy | Aug 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050234388 | Amos et al. | Oct 2005 | A1 |
20050273160 | Lashinski et al. | Dec 2005 | A1 |
20060025855 | Lashinski et al. | Feb 2006 | A1 |
20060030920 | Ben-Muvhar | Feb 2006 | A1 |
20060106449 | Ben Muvhar | May 2006 | A1 |
20060106450 | Ben Muvhar | May 2006 | A1 |
20060122692 | Gilad et al. | Jun 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20070038259 | Kieval et al. | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070179590 | Lu et al. | Aug 2007 | A1 |
20070198097 | Zegdi | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20080027268 | Buckner | Jan 2008 | A1 |
20080097497 | Assad et al. | Apr 2008 | A1 |
20080140110 | Spence | Jun 2008 | A1 |
20080194905 | Walsh | Aug 2008 | A1 |
20080208329 | Bishop et al. | Aug 2008 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090112312 | LaRose et al. | Apr 2009 | A1 |
20090149950 | Wampler | Jun 2009 | A1 |
20090198315 | Boudjemline | Aug 2009 | A1 |
20090270974 | Berez | Oct 2009 | A1 |
20100023046 | Heidner et al. | Jan 2010 | A1 |
20100057192 | Celermajer | Mar 2010 | A1 |
20100125288 | Gelfand et al. | May 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100222633 | Poirier | Sep 2010 | A1 |
20100249911 | Alkhatib | Sep 2010 | A1 |
20100286758 | Berglund | Nov 2010 | A1 |
20110021864 | Criscione et al. | Jan 2011 | A1 |
20110046710 | Mangiardi et al. | Feb 2011 | A1 |
20110054589 | Bashiri et al. | Mar 2011 | A1 |
20110071624 | Finch et al. | Mar 2011 | A1 |
20110098800 | Braido et al. | Apr 2011 | A1 |
20110098802 | Braido et al. | Apr 2011 | A1 |
20110213408 | Gross et al. | Sep 2011 | A1 |
20110306916 | Nitzan et al. | Dec 2011 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120123195 | Woodruff et al. | May 2012 | A1 |
20120123556 | Durgin | May 2012 | A1 |
20120149978 | Olivera et al. | Jun 2012 | A1 |
20120165928 | Nitzan et al. | Jun 2012 | A1 |
20120310323 | Roeder | Dec 2012 | A1 |
20130073026 | Russo et al. | Mar 2013 | A1 |
20130096580 | Cohn et al. | Apr 2013 | A1 |
20130103162 | Costello | Apr 2013 | A1 |
20130172981 | Gross et al. | Jul 2013 | A1 |
20130178750 | Sheehan et al. | Jul 2013 | A1 |
20130261531 | Gallagher et al. | Oct 2013 | A1 |
20130274648 | Weinberger | Oct 2013 | A1 |
20140012181 | Sugimoto | Jan 2014 | A1 |
20140039537 | Carrison | Feb 2014 | A1 |
20140128957 | Losordo et al. | May 2014 | A1 |
20140155997 | Braido | Jun 2014 | A1 |
20140277425 | Dakin | Sep 2014 | A1 |
20140303710 | Zhang et al. | Oct 2014 | A1 |
20140324094 | Weber | Oct 2014 | A1 |
20140350565 | Yacoby et al. | Nov 2014 | A1 |
20140350668 | Delaloye et al. | Nov 2014 | A1 |
20140364686 | McClurg | Dec 2014 | A1 |
20150073544 | Gorman, III et al. | Mar 2015 | A1 |
20150148896 | Karapetian et al. | May 2015 | A1 |
20150174308 | Oran et al. | Jun 2015 | A1 |
20160151153 | Sandstrom et al. | Jun 2016 | A1 |
20160296317 | Timmermans et al. | Oct 2016 | A1 |
20170042551 | Celermajer et al. | Feb 2017 | A1 |
20170065402 | Tozzi et al. | Mar 2017 | A1 |
20170113026 | Finch | Apr 2017 | A1 |
20170172771 | Bruckheimer et al. | Jun 2017 | A1 |
20170215885 | Goldie et al. | Aug 2017 | A1 |
20170216025 | Nitzan et al. | Aug 2017 | A1 |
20170325946 | Bell et al. | Nov 2017 | A1 |
20170340441 | Rowe | Nov 2017 | A1 |
20170340460 | Rosen et al. | Nov 2017 | A1 |
20170367855 | Jenni | Dec 2017 | A1 |
20180021156 | Ben-Muvhar et al. | Jan 2018 | A1 |
20180036109 | Karavany et al. | Feb 2018 | A1 |
20180085128 | Bellomo et al. | Mar 2018 | A1 |
20180092732 | Kringle et al. | Apr 2018 | A1 |
20190000483 | Mogensen | Jan 2019 | A1 |
20190307459 | Celermajer et al. | Oct 2019 | A1 |
20200000582 | Lashinski et al. | Jan 2020 | A1 |
20200205962 | Karavany et al. | Jul 2020 | A1 |
20200229956 | Jackson et al. | Jul 2020 | A1 |
20200289299 | Bruckheimer et al. | Sep 2020 | A1 |
20200297516 | Bellomo et al. | Sep 2020 | A1 |
20200352696 | Radhakrishnan et al. | Nov 2020 | A1 |
20210161643 | Totten et al. | Jun 2021 | A1 |
20210169634 | Karavany et al. | Jun 2021 | A1 |
20210290358 | Goodman et al. | Sep 2021 | A1 |
20210338465 | Bruckheimer et al. | Nov 2021 | A1 |
20220015889 | Lima et al. | Jan 2022 | A1 |
20220022881 | Celermajer et al. | Jan 2022 | A1 |
20220039938 | Karavany et al. | Feb 2022 | A1 |
20220117765 | Yacoby et al. | Apr 2022 | A1 |
20220241063 | Karavany et al. | Aug 2022 | A1 |
Number | Date | Country |
---|---|---|
2 970 237 | Jun 2016 | CA |
1430490 | Jul 2003 | CN |
1672644 | Sep 2005 | CN |
101687088 | Mar 2010 | CN |
102764170 | Nov 2012 | CN |
102961200 | Mar 2013 | CN |
103202735 | Jul 2013 | CN |
103930042 | Jul 2014 | CN |
204106100 | Jan 2015 | CN |
105392431 | Mar 2016 | CN |
10102045 | Jan 2003 | DE |
1576929 | Sep 2005 | EP |
1849440 | Oct 2007 | EP |
1870057 | Dec 2007 | EP |
2567663 | Mar 2013 | EP |
3300672 | Apr 2018 | EP |
WO 2001035861 | May 2001 | WO |
WO 03028522 | Apr 2003 | WO |
WO2003028522 | Apr 2003 | WO |
WO 2005084730 | Sep 2005 | WO |
WO 2006131930 | Dec 2006 | WO |
WO2007129220 | Nov 2007 | WO |
WO2007144782 | Dec 2007 | WO |
WO 2011156176 | Dec 2011 | WO |
WO 2013096548 | Jun 2013 | WO |
WO 2016013006 | Jan 2016 | WO |
WO2016096529 | Jun 2016 | WO |
WO 2016096529 | Jun 2016 | WO |
WO 2017024357 | Feb 2017 | WO |
WO 2017194437 | Nov 2017 | WO |
WO 2018225059 | Dec 2018 | WO |
WO 2020023512 | Jan 2020 | WO |
WO 2020109979 | Jun 2020 | WO |
WO 2023281507 | Jan 2023 | WO |
Entry |
---|
Communication Pursuant to Article 94(3) EPC dated Jan. 3, 2020 From the European Patent Office Re. Application No. 17193799.8. (4 Pages). |
European Search Report and the European Search Opinion dated Jan. 19, 2018 From the European Patent Office Re. Application No. 17193799.8. (9 Pages). |
Final Official Action dated Jul. 2, 2020 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (16 pages). |
Official Action dated Dec. 3, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (18 pages). |
Ahmadi et al. “Percutaneously Adjustable Pulmonary Artery Band”, The Annals of the Thoracic Surgery, 60(6/Suppl.): S520-S522, Dec. 1995. |
Amahzoune et al. “A New Endovascular Size Reducer for Large Pulmonary Outflow Tract”, European Journal of Cardio-Thoracic Surgery, 37(3): 730-752, Available Online Oct. 2, 2009. |
Basquin et al. “Transcatheter Valve Insertion in a Model of Enlarged Right Ventricular Outflow Tracts”, The Journal of Thoracic and Cardiovascular Surgery, 139(1): 198-208, Jan. 2010. |
Boudjemline et al. “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract. An Experimental Study”, Journal of the American College of Cardiology, 43(6): 1082-1087, Mar. 17, 2004. |
Boudjemline et al. “Steps Toward the Peercutaneous Replacement of Atrioventricular Valves. An Experimental Study”, Journal of the American College of Cardiology, 46(2): 360-365, Jul. 19, 2005. |
Corno et al. “The Non-Circular Shape of FloWatch®-PAB Prvents the Need for Pulmonary Artery Reconstruction After Banding. Computational Fluid Dynamics and Clinical Correlations”, European Journal of Cardio-Thoracic Surgery, 29(1): 93-99, Available Online Dec. 6, 2005. |
DiBardino et al. “A Method of Transcutaneously Adjustable Pulmonary Artery Banding for Staged Left Ventricular Retraining”, The Journal of Thoracic and Cardiovascular Surgery, 144(3): 553-556, Published Online Feb. 9, 2012. |
Horita et al. “Development of a Reexpandable Covered Stent for Children”, Catheterization and Cardiovascular Interventions, 68(5): 727-734, Published Online Oct. 12, 2006. |
Le Bret et al. “A New Percutaneously Adjustable, Thoracoscopically Implantable, Pulmonary Artery Banding: An Experimental Study”, The Annals of Thoracic Surgery, 72(4): 1358-1361, Oct. 31, 2001. |
Mollet et al. “Development of a Device for Transcatheter Pulmonary Artery Banding: Evaluation in Animals”, European Heart Journal, 27(24): 3065-3072, Published Ahead of Print Oct. 31, 2006. |
Mollet et al. “Off-Pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Transcatheter Approach Using An Intravascular Infundibulum Reducer”, Pediatric Research, 62(4): 428-433, Oct. 2007. |
Nakahata et al. “Percutaneous Bilateral Pulmonary Artery Banding Using a Re-Expandable Covered Stent: Preliminary Animal Study”, The Kisato Medical Journal, 41(2): 165-169, Sep. 2011. |
Schranz et al. “Pulmonary Artery Banding in Infants and Young Children With Left Ventricular Dilated Cardiomyopathy: A Novel Therapeutic Strategy Before Heart Transplantation”, The Journal of Heart and Lung Transplantation, 32(5): 475-481, Published Online Feb. 12, 2013. |
Talwar et al. “Changing Outcomes of Pulmonary Artery Banding With the Percutaneoulsy Adjustable Pulmonary Artery Band”, The Annals of Thoracic Surgery, 85(2): 593-598, Feb. 2008. |
Watanabe et al. “How to Clamp the Main Pulmonary Artery During Video-Assisted Thorascopic Surgery Lobectomy”, European Journal of Cardio-Thoracic Surgery, 31(1): 129-131, Published Online Nov. 29, 2006. |
Notice of Allowance dated Mar. 18, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (22 pages). |
Office Action dated Oct. 19, 2020 From the Israel Patent Office Re. Application No. 254791 and its Translation Into English. (6 Pages). |
Final Official Action dated Dec. 21, 2021 from US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (6 pages). |
International Preliminary Report on Patentability dated Dec. 19, 2019 From the International Bureau of WIPO Re. Application No. PCT/IL2018/050604. (9 Pages). |
International Preliminary Report on Patentability dated Jan. 24, 2017 From the International Bureau of WIPO Re. Application No. PCT/IL2015/050745. (8 Pages). |
International Search Report and the Written Opinion dated Nov. 5, 2015 From the International Searching Authority Re. Application No. PCT/IL2015/050745. (14 Pages). |
International Search Report and the Written Opinion dated Sep. 20, 2018 From the International Searching Authority Re. Application No. PCT/IL2018/050604. (12 Pages). |
Notice of Allowance dated Jan. 24, 2020 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (8 pages). |
Office Action dated Jun. 7, 2021 From the Israel Patent Office Re. Application No. 250181 and its Translation Into English. (7 Pages). |
Office Action dated May 12, 2020 From the Israel Patent Office Re. Application No. 250181 and its Translation Into English. (7 Pages). |
Official Action dated Feb. 2, 2018 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (15 pages). |
Official Action dated Jun. 5, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (6 Pages). |
Official Action dated Sep. 6, 2018 From the US Patent and Trademark Office Rc. U.S. Appl. No. 15/327,075. (9 pages). |
Official Action dated Jul. 14, 2021 from the US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (16 pages). |
Official Action dated Dec. 20, 2018 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (12 pages). |
Official Action dated Sep. 27, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (6 Pages). |
Restriction Official Action dated Apr. 30, 2021 From the US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (7 Pages). |
Supplementary European Search Report and the European Search Opinion dated Feb. 4, 2021 From the European Patent Office Re. Application No. 18812772.4. (7 Pages). |
Supplementary European Search Report and the European Search Opinion dated Feb. 9, 2018 From the European Patent Office Rc. Application No. 15825239.5. (7 Pages). |
Bailey “Back to the Future! Bold New Indication for Pulmonary Artery Banding”, The Journal of Heart and Lung Transplantation, 32(5): 482-483, May 1, 2013. |
Schranz et al. “Pulmonary Artery Banding in Infants and Young Children With Lleft Ventricular Dilated Cardiomyopathy: A Novel Therapeutic Strategy Before Heart Transplantation”, The Journal of Heart and Lung Transplantation, 32(5):475-481, May 31, 2013. |
English Summary dated Mar. 17, 2022 of Notification of Office Action and Search Report dated Mar. 9, 2022 From the State Intellecutal Property Office of the People's Republic of China Re. Application No. 201880036104.4. (2 Pages). |
Notification of Office Action and Search Report dated Mar. 9, 2022 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201880036104.4. (8 Pages). |
Notification of Office Action and dated Jul. 5, 2022 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201710896715.3 and its Summary in English. (5 Pages). |
Advisory Action dated Jun. 29, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (8 pages). |
Official Action dated Aug. 13, 2021 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (19 pages). |
Notification of Office Action and Search Report dated Nov. 30, 2021 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201710896715.3 and its Summary in English. |
Official Action dated Aug. 16, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 16/888,872. (43 pages). |
Interview Summary dated Apr. 13, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (2 pages). |
Office Action dated Jul. 13, 2022 From the Israel Patent Office Re. Application No. 250181. (5 Pages). |
Translation Dated Jul. 20, 2022 of Office Action dated Jul. 13, 2022 From the Israel Patent Office Re. Application No. 250181. (4 Pages). |
Final Official Action dated Feb. 22, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (23 pages). |
Santamore et al. “Ventricular Interdependence: Significant Left Ventricular Contributions to Right Ventricular Systolic Function”, Progress in Cardiovascular Diseases, 40(4): 289-308, Jan./Feb. 1998. |
Official Action dated Oct. 14, 2022 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (24 pages). |
Notice of Allowance dated Jun. 6, 2023 Together With Inteview Summary dated May 22, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (22 pages). |
Office Action dated Jun. 20, 2023 From the Israel Patent Office Re. Application No. 271184. (4 Pages). |
Office Action dated Oct. 30, 2022 From the Israel Patent Office Re. Application No. 271184. (4 Pages). |
International Search Report and the Written Opinion dated Oct. 12, 2022 From the International Searching Authority Re. Application No. PCT/IL2022/050724. (15 Pages). |
Communication Pursuant to Article 94(3) EPC dated May 24, 2023 From the European Patent Office Re. Application No. 17193799.8. (4 Pages). |
Notice of Allowance dated Mar. 22, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 16/888,872. (16 pages). |
Number | Date | Country | |
---|---|---|---|
20200360024 A1 | Nov 2020 | US |
Number | Date | Country | |
---|---|---|---|
62400695 | Sep 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15716667 | Sep 2017 | US |
Child | 16984166 | US |